Imaging cellular metabolic heterogeneity in cancer

Optical metabolic imaging (OMI) quantifies the fluorescence intensities and lifetimes of NADH and FAD using two-photon microscopy. OMI monitors single cells in tumors, thus aiding in the development and implementation of effective cancer treatments.